Some good reading from 420 mgazine Court Ruling Won't Sway

New Post Public Reply Private Reply Replies (1) Message Board
goldeneagle any1butyou #8150

Some good reading from 420 mgazine

Court Ruling Won't Sway Health Canada On Marijuana
others/\
http://www.420magazine.com/forums/internation...juana.html

Court Ruling Won't Sway Health Canada On Marijuana
Health Canada isn't backing down after a federal court ruled against the government's efforts to ban medical marijuana users from growing their own pot.

In the wake of Friday's court decision, the federal department which runs the medical pot program said it will "review the ruling and consider its options," but indicated it wants to maintain its current approach.

"While the Courts have said there must be reasonable access to marijuana for medical purposes, Health Canada’s goal is to treat dried marijuana as much as possible like other narcotic drugs used for medical purposes," a spokesperson told HuffPost Canada in an email.

The Federal Court ruling is a small victory for patients and a potential setback to the Conservative government’s plans to turn cannabis into a regulated billion-dollar industry.

Judge Michael Manson said patients would be “irreparably harmed” by new medical marijuana regulations banning home grow operations starting April 1.

"I find that the nature of the irreparable harm that the applicants will suffer under the (updated regulations) constitutes a 'clear case', which outweighs the public interest in wholly maintaining the enacted regulations,” Manson said in a written statement released Friday.

The ruling means patients who already hold a Health Canada-issued authorization to possess are exempt from the new rules forbidding them to grow their own supply and allows them to possess up to 150 grams of marijuana.

The department warned patients in a blunt press release earlier this month that they would have to destroy all of their plants and provide a letter to confirm they had done so, or their names would be handed over to police.

The court's ruling appears to have made this policy unenforceable. John Conroy, the lawyer representing the patients’ coalition, argues the new legislation is unconstitutional because it forces them to choose between liberty (which they could lose if they continue to grow their own) and their health (if they cannot afford their regular doses under the new system, their health could deteriorate).

“Let’s not take away the right of the patients to be able to produce for themselves at less cost and to have quality control over what they do,” he said.

“If we’re in a position where people can access this medicine without having to suffer the way many, many Canadians do in relation to other types of drugs that they can’t afford or that aren’t covered by various plans, then I think that’s a victory for all patients.”

The government agency last year announced plans to repeal the Marihuana Medical Access Program (yes, the government still spells it with an “h”), which it has said jeopardizes public safety because of mould and fire risk from grow-ops. The government also believes the program is susceptible to criminal abuse by those who resell their products on the black market.

Starting April 1, the system was to be replaced with the more tightly controlled Marihuana for Medical Purposes Regulations, under which Canadian medical marijuana patients will be required to get their doses from one of a handful of licensed producers.

Their prices will range from $4 to $12 a gram. However, some of Canada’s 40,000 medical marijuana patients argue that they will be unable to afford their medicine once they are forced to buy from large-scale suppliers because they can grow it themselves at a fraction of the price — for as little as $1 a gram.

An overhaul of the medical marijuana system is now on ice at least until a trial date can be set, which is expected to happen within the next year.

“Upholding their constitutional rights pending trial is significant as far as we’re concerned,” Conroy said. “But trial still involves additional evidence and additional issues so we’ll just have to see what happens at that time.”

Some 13 companies have been granted licences to grow and sell marijuana on a commercial scale, many of them just within the past few months.

04-1-14
The new licensed producers had been scrambling to meet the April 1 deadline, when they expected demand for their product to spike.

Many producers are still new and their plants have yet to mature, leaving their product scarce. The injunction does not affect the new licensing system.

The Supreme Court has previously ruled that patients who have doctor’s approval must have reasonable access to a legal supply of marijuana.

Still, Health Canada makes it clear that it does not endorse medical marijuana, and doctors have been reluctant to prescribe it, saying they have yet to see conclusive studies that show benefits outweighing its potential harm.

regulated in 2001,
Canada first regulated medical marijuana in 2001, but only after the government was forced to do so by the courts.

A year earlier, an Ontario court concluded the law at the time violated the rights of sick people who used pot to alleviate their symptoms.

The number of people authorized to possess — and often grow — marijuana has increased to 37,000 this year from fewer than 100 in 2001.

The federal government says the current licences translate to about 3.5 million plants.

In this week's court hearing, a government lawyer said there is no constitutional right to cheap medicine, and he argued there was no scientific evidence to show specific strains of marijuana are better suited to particular illnesses or patients.

The patients' lawyer suggested the government had offered little concrete evidence that the medical marijuana system actually poses as many risks as it claims.

While the injunction application didn't specifically target the new commercial licensing regime, the government argued that allowing some patients to continue growing their own pot would prevent the fledgling medical marijuana industry from fully developing.

The Federal Court ruling notes the potential for the injunction to affect the commercial market, but Manson writes the impact will be short-lived and won't have a major impact on the government's ability to implement its regulations.

A trial has not been scheduled, though Manson's judgment states a trial is expected within nine to twelve months.


[-chart]www.420magazine.com/gallery/data/1412/growingfacility.jpg[/chart]

News Moderator - The General @ 420 MAGAZINE ®
Source:
http://www.Huffingtonpost.ca
Author: Sunny Freeman
Contact: Contact us
Website: Court Ruling Won't Sway Health Canada On 'Narcotic' Marijuana

420 Magazine® News Team
Creating Cannabis Awareness Since 1993

Got News? Please submit it to: news@420magazine.com

International Cannabis & Hemp News Daily
Please Visit the 420 Contests
Please Visit our Sponsors
Please Help Support Our Mission
Forum Guidelines - Please Read Before Posting
420 Photo Gallery Tutorial - How to Post Photos
Follow us on Twitter, YouTube and Facebook 

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Understanding Criminal Threat Charges in Kansas

Updated Category News Views 3

The Intricacies of Criminal Threat Cases in Kansas Let's cut straight to it: not all heated exchanges land you in court, but words can slap you with a criminal threat charge in Kansas if mishandled. A simple spat can turn legal nightmare, making it crucial to grasp the nuances of these cases. What sets them apart from other charges is the absence of physical...

Continue Reading
Claigan Webinar Tackles Prop 65 Warnings for 2028

Updated Category News Views 12

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

Continue Reading
HiBy Unveils Cyberpunk 2077 Gaming Audio Line

Updated Category News Views 4

HiBy Hits the Gaming Scene with Cyberpunk Flair It's a wild world when audio tech and gaming collide outside of the usual suspects. HiBy's latest move is a bold pivot into the gaming universe, launching an audacious collaboration with, of all things, the cybernetic chaos of Cyberpunk 2077. You can almost feel the underlying scrappiness of Night City embedded into a couple...

Continue Reading
LifeLabs' AI Program: A Manager's New Toolbox

Updated Category News Views 8

Management In the Age of AI: New Frontiers Gone are the days when a simple software update meant staying competitive. We're in a new era, folks—one where AI isn't just a handy tool—it's reshaping entire industries. But here's the kicker: all the fancy tech in the world won't do squat without savvy managers who know how to drive adoption. Yup, that's the naked truth,...

Continue Reading
Schweid & Sons Reveals New Marinated Steak Tips Line

Updated Category News Views 5

No More Prep Dilemmas: Schweid & Sons Unveils Steak Tips Packing a punch in the protein aisle, Schweid & Sons throws down the gauntlet with their latest culinary innovation — Marinated Steak Tips. These aren't just your run-of-the-mill cuts, folks. We're talking premium Tri-Tip, butcher-trimmed to perfection, and marinated in both Cajun and Teriyaki styles. It's all...

Continue Reading
SOA Elects New Leaders for 2026: A Look Ahead

Updated Category News Views 6

A New Lineup for SOA's Board in 2026 On the financial frontlines, few organizations hold the clout that the Society of Actuaries (SOA) wields. With their latest round of elections completed, they've named five fresh Board members along with both a new President Elect and Vice Chair for the upcoming 2026-2027 term. These folks are gearing up to take the stage right after...

Continue Reading
Klydoclock's Bold Move: Licensing International Boost

Updated Category News Views 17

Revolutionizing Timekeeping with Art There’s this clock outfit, Klydoclock, that’s flipping the script on how we see time and art melding together. You see, they’ve taken those static old tick-tock reminders of the hour and juiced 'em up with animated art, turning your wall clock into something more akin to a mini art exhibit right in your living room. Ever heard of...

Continue Reading
Multiply's AI Agent Tackles $126K Google Ads Waste

Updated Category News Views 5

AI Steps In Where Marketers Hit a Wall Picture this: marketers drowning in search terms flying at them faster than they can blink. Multiply's new AI-powered Ad Spend Recovery Agent steps in, claiming to save an eye-watering $126,000 per year by cutting Google Ads waste. Talk about having a hawk-eyed auditor sifting through your accounts. Shaking Up Traditional Automation...

Continue Reading
Beasley and Vegas Golden Knights Partner for Broadcast

Updated Category News Views 4

Strategic Moves on the Airwaves The Vegas Golden Knights are skating into a new era of broadcasting. Teaming up with Beasley Media Group, they've inked a multiyear deal that makes the media outfit their official audio partner. Dropping the puck on this relationship means folks in Southern Nevada can catch the action on Beasley's English and Spanish stations. It's a hefty...

Continue Reading
Books-A-Million's Impactful 2026 Coffee for Troops Campaign

Updated Category News Views 3

A Modest Cup, A Massive Impact Ever wonder how something as simple as a bag of coffee could bridge the gap between a service member far from home and their loved ones? Well, Books-A-Million has got that figured out, and they're taking it to another level with their 2026 Coffee for the Troops campaign. This isn't just about a hot brew; it's about stirring up a storm of...

Continue Reading

Top 5 Most Recently Viewed Articles

EA Analyst Day Sparks Anticipation for Future Growth

Updated Category News Views 64

EA Analyst Day Sparks Excitement for Future Growth Oppenheimer has recently reaffirmed its Outperform rating for Electronic Arts (NASDAQ: EA) and set a price target of $170.00, creating a positive buzz ahead of the company's eagerly awaited analyst day event. This occasion not only allows Electronic Arts to share its long-term strategic plans but also serves to boost...

Continue Reading
Investing in Goldman Sachs: A 20-Year Journey of Growth

Updated Category News Views 153

Understanding the Long-Term Investment Potential Many investors often wonder about the growth potential of their investments over the long term. One stark example is an investment in the Goldman Sachs Group (NASDAQ: GS). Over the past two decades, this stock has not only provided stability but has consistently outperformed many market indices, showcasing its lasting...

Continue Reading
Geron Corporation Faces Class Action: Investors May Take Charge

Updated Category News Views 146

Geron Corporation Faces Class Action Lawsuit The law firm Robbins Geller Rudman & Dowd LLP has stepped forward to announce that investors who acquired shares of Geron Corporation (NASDAQ: GERN) during a specified period have a crucial opportunity. This chance allows those impacted by substantial losses to take a lead role in a class action lawsuit against the company. The...

Continue Reading
Trump Media's Global Expansion with Truth+ Streaming Service

Updated Category News Views 215

Trump Media & Technology Group Launches Truth+ Trump Media & Technology Group Corp. (NASDAQ: DJT) has officially unveiled its streaming service, Truth+, to audiences worldwide. This exciting launch represents a significant step for the company as it branches out into the digital media landscape, which has become increasingly competitive. What You Need to Know The...

Continue Reading
Sierra Metals Shareholders Stand Firm Against Alpayana's Bid

Updated Category News Views 131

Sierra Metals Shareholders Stand Firm Against Alpayana's Bid Sierra Metals Inc (TSX: SMT | OTCQX: SMTSF) has recently informed stakeholders that a considerable majority of its shareholders have signaled their refusal to accept Alpayana S.A.C.'s proposed takeover offer. The bid, which suggests acquiring shares for C$0.85 each, has been deemed inadequate by shareholders...

Continue Reading